The growth of Femtech is estimated to reach about USD 30,721.9 million in 2025 and to expand further to about USD 47,232.0 million by 2035. This indicates a compound annual growth rate (CAGR) of growth at about 4.4% through the forecast period.

Country-wise Insights

Competitive Outlook

In 2023, the femtech market was worth almost 52 billion U.S. dollars worldwide. After sustained growth, the market was forecast to reach over 117 billion U.S. dollars by 2029.

The Femtech Market Report is Segmented by Type (Devices, Software, and Services), Application (Reproductive Health & Contraception, Pregnancy & Nursing Care, Menstrual Health Management, Pelvic & Uterine Health, and More), End User (Hospitals & Maternal Centers, and More), and Geography (North America, Europe, Asia-Pacific, Middle East & Africa, South America). The Market Forecasts are Provided in Terms of Value (USD).

Femtech or Female Technology market is forecasted to grow at a rate of 12.9% in terms of value, from USD 22.1 billion in 2024 to reach USD 75.3 billion by 2034. In recent years, both the government and numerous public and private corporations have invested extensively in femtech, which will boost th...

The total global market for femtech products and services was valued at some **** billion U.S. dollars in 2020. It was forecast that this value will increase to over ** billion dollars by 2025. The term femtech is relatively new and refers to products, services, and software based on new technologies and focusing on women's health.

Global Femtech market size is expected to reach $98.08 billion by 2029 at 20.5%, segmented as by type, devices, software, services, other types

FemTech Market is projected to reach USD 206.84 billion by 2033, growing at a CAGR of 15.51% from 2025-2033.

Femtech Market Outlook

According to our latest research, the femtech market size reached USD 36.2 billion globally in 2024, demonstrating robust growth driven by increasing awareness and adoption of digital health solutions tailored specifically for women. The market is expected to expand at a CAGR of 13.5% from 2025 to 2033, reaching a forecasted value of USD 104.5 billion by 2033. This impressive growth trajectory is primarily supported by technological advancements in women’s health, rising investment in female-focused healthcare startups, and a growing emphasis on personalized medicine, as per our latest research findings.

One of the most significant growth factors for the femtech market is the increasing prevalence of chronic and reproductive health conditions among women worldwide. Rising incidences of polycystic ovary syndrome (PCOS), endometriosis, infertility, and menopause-related complications have created a substantial demand for specialized health solutions. Femtech, encompassing a range of digital applications, wearable devices, and connected services, is addressing these needs by providing women with tools for tracking menstrual cycles, monitoring fertility, and managing pregnancy and menopause symptoms. Furthermore, the integration of artificial intelligence and data analytics into femtech platforms has enabled more personalized and predictive healthcare, empowering women to make informed decisions about their health and wellness.

Another driving force behind the expansion of the femtech market is the shift in societal attitudes toward women’s health and wellness. Increased advocacy for gender-specific healthcare, coupled with policy initiatives supporting women’s health rights, has led to greater visibility and acceptance of femtech solutions. With more women taking proactive roles in managing their health, demand for direct-to-consumer (DTC) products and services has surged. Additionally, the proliferation of smartphones and internet connectivity has facilitated widespread access to mobile health applications and telemedicine services, further accelerating market growth. The surge in venture capital and private equity investments into femtech startups is also fueling innovation and expanding the reach of these solutions across diverse demographics.

The femtech market’s growth is also being propelled by the expansion of healthcare infrastructure and increasing collaboration between technology companies, healthcare providers, and research institutions. Strategic partnerships and mergers are fostering the development of integrated solutions that combine diagnostics, remote monitoring, and personalized care. Moreover, the COVID-19 pandemic highlighted the importance of remote health management, leading to a surge in telehealth adoption and reinforcing the relevance of femtech in delivering accessible and convenient care. As the ecosystem matures, regulatory support and standardization are expected to streamline product approvals and enhance consumer trust, further catalyzing market expansion.

Regionally, North America remains the dominant force in the femtech market, accounting for the largest share due to high healthcare expenditure, advanced digital infrastructure, and a strong presence of leading femtech companies. Europe follows closely, benefiting from supportive regulatory frameworks and increasing awareness of women’s health issues. The Asia Pacific region is emerging as a lucrative market, driven by rising disposable incomes, growing urbanization, and increased focus on maternal and reproductive health. Latin America and the Middle East & Africa are also witnessing gradual adoption, supported by improving healthcare access and targeted awareness campaigns. Each region presents unique opportunities and challenges, shaping the overall growth trajectory of the global femtech market.

Component Analysis

The femtech market by component is segmented into software, devices, and services, each playing a pivotal role in shaping the indust

Snapshot img

Femtech Market Size 2025-2029

The femtech market size is forecast to increase by USD 50.73 billion at a CAGR of 12.7% between 2024 and 2029.

The market is experiencing significant growth due to the increasing prevalence of conditions such as infertility and obesity-related health issues in women. These issues have led to a greater awareness and demand for advanced technologies and solutions designed specifically for women's health. However, the market is not without challenges. Lack of investment and insufficient research and development in this sector have hindered the growth of the market.
Despite these challenges, the market presents a vast opportunity for companies seeking to innovate and address unmet needs in women's health. By focusing on developing solutions for conditions with high prevalence and investing in research and development, companies can capitalize on this growing market and make a positive impact on women's lives. The market encompasses a burgeoning sector of digital health solutions specifically designed for women's and female health. This dynamic market is characterized by the development and implementation of innovative technologies, including digital therapeutics, health data management systems, industry partnerships, and remote monitoring solutions.

What will be the Size of the Femtech Market during the forecast period?

Request Free Sample

Digital health policy and regulatory frameworks continue to evolve, enabling the integration of femtech offerings into the digital health ecosystem. Key trends include the adoption of mobile health, wearable technology, and biometric monitoring for personalized medicine and lifestyle interventions. Digital diagnostics and predictive analytics are transforming healthcare by enabling early detection and prevention of health issues.

How is this Femtech Industry segmented?

The femtech industry research report provides comprehensive data (region-wise segment analysis), with forecasts and estimates in 'USD million' for the period 2025-2029, as well as historical data from 2019-2023 for the following segments.

End-user

  Direct-to-consumer
  Hospitals
  Fertility clinics
  Others


Type

  Devices
  Software
  Services
  Others


Application

  Menstruation care and fertility tracking
  Pregnancy and nursing care
  General health and wellness
  Menopausal health


Geography

  North America

    US
    Canada
    Mexico


  Europe

    France
    Germany
    Italy
    UK


  Asia

    China
    India


  Rest of World (ROW)

By End-user Insights

The direct-to-consumer segment is estimated to witness significant growth during the forecast period. Femtech businesses are technology-driven companies focusing on addressing women's health concerns through innovative solutions. These businesses primarily target issues related to contraception, pelvic and sexual health, menopause, menstrual health, and fertility, as well as conditions that disproportionately affect women. The stigma surrounding women's health issues, such as menstruation, sexual, and pelvic health, is being challenged by these companies. Maven Clinic, a virtual clinic, is an example of a femtech business that offers services to women and families. Initially focusing on maternity care, it has since expanded to cater to various stages of the reproductive cycle. Femtech solutions include wearable devices for sleep tracking and fitness, menstrual cycle management apps, contraception apps, and pregnancy planning apps, all utilizing advanced technologies like artificial intelligence, machine learning algorithms, and big data analytics.

Get a glance at the market report of share of various segments Request Free Sample

The Direct-to-consumer segment was valued at USD 14 billion in 2019 and showed a gradual increase during the forecast period. These businesses prioritize data privacy and regulatory compliance while providing personalized experiences, patient engagement, and user-centered design. They aim to empower women through digital health literacy and telehealth platforms, fostering online communities and support groups for mental health, hormonal health, and sexual well-being. Investment firms and venture capital are increasingly recognizing the potential of femtech, leading to the emergence of digital therapeutics and AI-powered diagnostics. Lifestyle management, nutrition tracking, ovulation prediction, and stress management are additional areas where femtech businesses are making a significant impact. By integrating smart sensors, virtual care, and cloud computing, these companies are driving the digital transformation of healthcare systems, collaborating with insurance companies and healthcare providers to offer comprehensive, accessible, and affordable solutions.

Regional Analysis

North America is estimated to contribute 48% to the growth of the global market during the forecast period

The global femtech market size was valued at USD 28.70 Billion in 2024, driven by the increasing focus of startups on developing improved healthcare for specific concerns among women across the globe. The market size is anticipated to grow at a CAGR of 12.40% during the forecast period of 2025-2034 to achieve a value of USD 92.37 Billion by 2034.

Femtech Market size was valued at USD 7.04 Billion in 2024 and is projected to reach USD 14.36 Billion by 2031, growing at a CAGR of 10.27% from 2024 to 2031.

The Femtech market is driven by increasing awareness and focus on women’s health, rising prevalence of chronic and lifestyle-related diseases among women, and advancements in digital health technologies. Growing investment in startups addressing reproductive health, menstrual care, fertility solutions, and menopause management fuels market growth. Additionally, the adoption of wearable devices, mobile health apps, and telemedicine tailored for women’s healthcare needs is expanding the market. Supportive government initiatives and rising societal acceptance of open conversations around women’s health further propel the adoption of Femtech solutions globally.

The global FemTech market is projected to grow from USD 51.80 billion in 2023 to USD 117.37 billion by 2029, growing at a CAGR of 14.61% from 2023 to 2029.

The femtech market is projected to reach USD 117.37 billion by 2029, growing at a CAGR of 14.61% from 2023 to 2029.

The global femtech market in 2019 is approximately USD 15,000 million and is anticipated to reach around USD 71,000 million by 2026. The anticipated CAGR for the femtech market is around 17% from 2020 to 2026.

Femtech Market Outlook 2032

The global femtech market size was USD 6.8 Billion in 2023 and is likely to reach USD 29.1 Billion by 2032, expanding at a CAGR of 17.5% during 2024–2032. The market is propelled by the growing demand for feminine hygiene and healthcare.



Increasing awareness of women's health issues is expected to drive the market during the forecast period. Femtech, a sector that applies technology to improve women's health. This burgeoning industry is leveraging the latest advancements in artificial intelligence, machine learning, and big data to address a wide range of women's health issues, from fertility solutions to menstrual tracking, and from pregnancy care to menopause support. The industry's innovative approach is not only revolutionizing women's healthcare but also opening up new opportunities for investors and entrepreneurs.

• 
  

  In November 2022, FemTech Lab, a London-based accelerator, inaugurated the FemTech Hub, a first-of-its-kind physical innovation hub expressly dedicated to women's health. This launch marks a significant stride in fostering a supportive ecosystem for the FemTech community.

  
  

Growing acceptance of digital health solutions is another key factor propelling the Femtech market. The COVID-19 pandemic accelerated the adoption of telehealth services, remote patient monitoring, and digital therapeutics, which are now integral components of the Femtech sector. These digital solutions are empowering women to take control of their health, offering them personalized care and convenience, and reducing the barriers to access healthcare services.



Rising investment in the Femtech sector is indicative of its potential. Venture capitalists, private equity firms, and even traditional healthcare companies are showing keen interest in the Femtech market, recognizing its potential to generate significant returns. This influx of investment is not only fueling the growth of existing Femtech companies but also encouraging the emergence of new startups, thereby expanding the range of solutions available to women worldwide.

<span style="font-size:20px;"

The female care and FemTech market in Japan grew from approximately **** billion Japanese yen in 2019 to over ** billion yen in 2021. More growth was estimated in 2022.

Femtech market categories the global market by component, by application. Market to grow at a significant CAGR of 17.18% during FY2019-2030. BIS Research provides deep market insight that will help your business to grow.

The total global market for femtech stood at some 17 billion U.S. dollars in 2018. Of this amount, around 3.7 billion dollars were generated by hospitals as the end user. The term femtech is relatively new and refers to products, services, and software based on new technologies and focusing on women's health.

In North America FemTech Market, The market has experienced significant momentum in recent years due to shifting cultural norms, increased venture funding, and the proliferation of mobile health technologies.

In India FemTech Market, The market has experienced significant momentum in recent years due to shifting cultural norms, increased venture funding, and the proliferation of mobile health technologies.